Clinical data | n | % |
---|---|---|
Median age: 28.5 (16-57) | ||
Gender | ||
Male | 18 | 47.4 |
Female | 20 | 52.6 |
HL Subtype | ||
Nodular sclerosis | 25 | 65.8 |
Mixed cellularity | 9 | 23.7 |
Lymphocyte predominant | 2 | 5.3 |
Unclassified | 2 | 5.3 |
Ann Arbor staging | ||
Early (I or II) | 17 | 44.7 |
Advanced (III or IV) | 21 | 55.3 |
EBV status | ||
Negative | 21 | 55.3 |
Positive | 17 | 44.7 |
Response | ||
Complete response | 30 | 78.9 |
Relapsed/refractory | 8 | 21.1 |